Select Medical Holdings Reports 3.8% Increase in Revenue for Q2 2025; Adjusted EBITDA Rises 6.1%
I'm PortAI, I can summarize articles.
Select Medical Holdings Corporation reported a 3.8% increase in revenue for Q2 2025, with income from continuing operations rising to $101 million, a 1% increase from Q2 2024. Adjusted EBITDA also rose by 6.1% to $54.8 million, with an adjusted EBITDA margin of 8.6%, slightly down from 8.7% in the previous year. No future financial guidance was provided in the report.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments